1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-(2-morpholinoethoxy)phenyl)urea

ID: ALA1213976

PubChem CID: 49863711

Max Phase: Preclinical

Molecular Formula: C20H21ClF3N3O3

Molecular Weight: 443.85

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(OCCN2CCOCC2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1

Standard InChI:  InChI=1S/C20H21ClF3N3O3/c21-18-6-3-15(13-17(18)20(22,23)24)26-19(28)25-14-1-4-16(5-2-14)30-12-9-27-7-10-29-11-8-27/h1-6,13H,7-12H2,(H2,25,26,28)

Standard InChI Key:  CYTGCHOMPXDYOU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 32  0  0  0  0  0  0  0  0999 V2000
    3.8833  -27.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8875  -28.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7375  -26.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4500  -25.7917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5958  -27.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0208  -25.8000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1667  -27.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9792  -27.0458    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1667  -26.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7417  -27.0333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750  -28.6750    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6042  -28.6667    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.8792  -29.0792    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4042  -26.2125    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.5875  -26.1875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3083  -26.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8708  -25.7833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3125  -27.4250    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.1208  -27.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4083  -25.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3083  -27.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4083  -27.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1208  -26.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8375  -27.4583    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2667  -27.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5500  -27.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6958  -27.4583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9792  -26.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6875  -25.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4083  -27.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  4  1  0
  4  9  1  0
  5  1  2  0
  6  3  1  0
  7  1  1  0
  8 25  1  0
  9  7  2  0
 10  3  2  0
 11  2  1  0
 12  2  1  0
 13  2  1  0
 14 30  1  0
 15  5  1  0
 16  6  1  0
 17 15  2  0
 18  5  1  0
 19 23  2  0
 20 16  2  0
 21 16  1  0
 22 21  2  0
 23 20  1  0
 24 19  1  0
 25 26  1  0
 26 24  1  0
 27  8  1  0
 28  8  1  0
 29 28  1  0
 30 27  1  0
  9 17  1  0
 22 19  1  0
 14 29  1  0
M  END

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abl1 Tyrosine-protein kinase ABL (212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.85Molecular Weight (Monoisotopic): 443.1224AlogP: 4.71#Rotatable Bonds: 6
Polar Surface Area: 62.83Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 11.57CX Basic pKa: 6.60CX LogP: 4.24CX LogD: 4.18
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.68Np Likeness Score: -1.90

References

1. Dietrich J, Hulme C, Hurley LH..  (2010)  The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec, Nexavar, and BIRB-796.,  18  (15): [PMID:20621496] [10.1016/j.bmc.2010.05.063]

Source